According to the National Council on Aging, approximately 80 percent of older adults have at least one chronic disease, and 77 percent have at least two. This population is at high risk for high blood pressure, diabetes, heart disease, and mental disorders including dementia and depression. Further, U.S. Pharmacist reports 44 percent of men and 57 percent of women older than 65 years take five or more medications per week, with 12 percent taking ten or more medications per week. And the list goes on.
It's easy to see then, the critical need for a pharmacist to have quick and comprehensive access to all potential areas of concern when interacting with a patient. Pharmacists have increasingly turned to technology providers to offer this capability, and most advanced systems do offer some degree of clinical alert functionality. However, an industry "standard" seems to be reliance on siloed alerts, whereby an alert might be generated when a certain drug is refilled, or when a patient expressed concern about a particular condition.
A better and more efficient solution is through the consolidated clinical alert solution offered by PrimeRx™. In a recent upgrade, functionality was added that allows visibility into all clinical checks via a single window. Using the example pf a "typical" senior citizen, this means the pharmacist would have immediate access to potential concerns about medication conflicts, adherence issues, as well as all chronic conditions.
Once the PrimeRx™ user is presented with this consolidated view of clinical checks, a quick click on a specific listing will direct the user to more detailed information. This advanced information can include access to the patient's medical records, or direct integration with Elsevier's national drug information database.
Consolidation of clinical alerts is an important step forward in allowing pharmacists to better manage patient care. With PrimeRx™, pharmacists have easy, comprehensive visibility into patient records, and are able to prioritize immediate areas of concern.